Our observation that BUB1 is upregulated across various lung cancer subtypes (Figure 1A–D) and its overexpression correlates with survival is consistent with earlier reports [13,14,15,27] and reemphasizes its potential as a crucial molecular target in lung cancer. Here, BUB1 is linked to lung carcinoma.